Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CGCI
August 03, 2020
Nature genetics

HTMCP scientists reveal the influence of HPV clades on molecular characteristics of HIV+ and HIV- cervical tumors from Ugandan patients. The study provides insights into the role of HIV infection, and how different HPV clades lead to specific molecular changes that could affect patient prognosis. 

CTD²
August 01, 2020
Trends Immunol.
CTD²
June 11, 2020
Blood

Study highlights the usage of FDA-approved tyrosine kinase inhibitors for treating leukemia patients with neurotrophic receptor tyrosine kinase mutations.

CTD²
June 01, 2020
Nature Chemical Biology

Integrated analysis of RNA-sequencing, proteomics, and phosphoproteomics data indicate doublecortin like kinase 1 (DCLK1) modulates proteins and pathways associated with cell motility in patient-derived pancreatic ductal adenocarcinoma (PDAC) organoids.

Pages

CSVXML